Sustained Viral Response (SVR) / Rapid Virologic Response (RVR) / Early Viral Response (EVR) / End of Treatment Response (EOT)
Duration of Pegylated Interferon plus Ribavirin May Be Tailored Based on Early Response - 1/04/08 Induction with High-dose Pegylated Interferon alfa-2a (Pegasys) Is More Effective than Standard Dosing for Achieving Rapid and Early Virological Response: The CHARIOT Study - 11/20/07 Virological Response and Safety Outcomes in Chronic Hepatitis C Patients Treated with Pegylated Interferon plus Taribavirin (Viramidine) - 8/10/07 72-week Treatment with Pegylated Interferon plus Ribavirin Can Produce Sustained Virological Response in Some Prior Relapsers - 6/15/07 Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure? - 6/01/07
A Follow-up Week 12 Viral Count Is Useful in Predicting SVR and Is 100% Accurate in Patients without Cirrhosis - 6/01/07
Statins Improve Sustained Response to Interferon-based Therapy in Small Study - 5/25/07
Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure? - 5/20/07
Selected Patients with Genotype 1 HCV May Attain SVR by Extending Treatment Duration to 72 Weeks - 4/24/07
Does SVR after Treatment with Pegasys/ribavirin Constitute a Cure for Chronic Hepatitis C? - 4/20/07
14 Weeks of Treatment with PegIntron plus Ribavirin Is Non-inferior to 24 Weeks in Rapid Responders with HCV Genotype 2 or 3 - 4/20/07
Rapid Virological Response Predicts Sustained Response and Can Help Optimize HCV Treatment - 4/17/07
Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients - 3/27/07
Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis - 3/27/07Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation 2/23/07HCV Continues to Replicate in the Livers of Patients with Sustained Response to Therapy 12/15/06
